Navigation Links
Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
Date:2/24/2013

by such statements. There can be no guarantee that omalizumab will be approved for any additional indications or labeling in any market. Nor can there be any guarantee that omalizumab will achieve any particular levels of revenue in the future. In particular, management's expectations regarding omalizumab could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; government, industry and general public pricing pressures; competition in general; unexpected manufacturing issues; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis
Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative prescription drugs used to treat a number of diseases and conditions, including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease and respiratory. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Locate
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
2. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
6. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
7. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
8. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
9. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
10. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
11. Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
(Date:3/3/2015)... March 3, 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... on hospital acute care and gastroenterology, today announced ... developments include top-line results from the Company,s Hepatoren ... Drug Application (sNDA) with pediatric data for Caldolor ... Phase II clinical trial. "The sNDA ...
(Date:3/3/2015)... industry report package offers the most up-to-date market data on the actual ... and in the top 10 global countries. Along with a global safety ... Australia , China , ... Italy , Japan , Russia ... United States The reports include historic ...
Breaking Medicine Technology:ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 3Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 4Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 5Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2
... Ohio, Nov. 8, 2011 Express Scripts, Inc., ... the US, has announced Rexam as its 2011 ...   http://photos.prnewswire.com/prnh/20111108/CL01742 ) This award recognizes ... Scripts and have shown continuous improvement in supplier ...
... Camfil Farr Air Pollution Control (APC) has produced a ... for Containment." U.S. and Canadian visitors can view the ... onto www.camfilfarrapc.com/videos/29 . David Steil, ... to approach dust collection in the pharmaceutical industry to ...
Cached Medicine Technology:Rexam Chosen as Express Scripts' Supplier of the Year 2
(Date:3/4/2015)... According to a new report published by ... U.S. suffer from gastroesophageal reflux disease (GERD), more commonly ... control acid production, but these can have side effects. ... problem and lead to other uncomfortable digestive conditions. ... lower esophageal sphincter does not function properly. Anti-reflux devices ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... non-profit WaterAid a total of $6.9 million, ... in Ghana, Mali, Niger and Burkina Faso. , The ... two areas. The first will focus on fixing water ... improving the skills of local people to maintain water ...
(Date:3/4/2015)... 04, 2015 A new dieting routine, ... in terms of extending life. Studies conducted ... new dieting routine can help extend life by increasing ... has long term benefits, many suffering from obesity are ... substitute is necessary. As an alternative to the new ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... defined as chemical preparations for enhancing the appearance of ... Manufactured using a wide variety of therapeutic agents to ... important lifestyle products in a society obsessed with physical ... largely reliant on the production and sales of cosmetics. ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The defibrillators ... defibrillators market. According to the report the global market ... from 2014 to reach $12.9 billion by 2019. It ... for the potential as well as established players in ... Asia-Pacific are positioned to witness growth at the highest ...
Breaking Medicine News(10 mins):Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3
... store most relevant information, study shows , THURSDAY, June 11 ... the sleeping brain seems to store only the most useful ... of 44 college students aged 18 to 22, the study ... period of learning, sleep can preserve the most important memories ...
... HOLLYWOOD, Calif., June 11 IPC The Hospitalist Company, ... hospitalist physician group practice company, announced today that it ... of Morristown, P.A. (AMAM). Based in Morristown, New ... Jersey and expands the Company,s national presence to 19 ...
... Healthcare Organizations Improve Security with an Accessible, Easy ... SAN FRANCISCO, June 11 nCircle, the leader ... Information Trust Alliance (HITRUST) announced today that nCircle ... and configuration assessments as a service for the ...
... automated external defibrillators , , WASHINGTON, June 11 ... arrest (SCA), The Richard B. and Lynne V. Cheney Cardiovascular ... the ReStart DC program on June 11. The goal of ... (AEDs) where large numbers of people gather throughout all eight ...
... Clinical Innovations has launched its new disposable circumcision device, ... reliable circumcision outcomes. Touted as the only significant innovation ... utilizes revolutionary technology to protect the glans, ensure adequate ... in a single actuation. , , The ...
... LIVERPOOL, England, June 11 ... nutrition, announces the launch of Neocate Nutra,the first ... amino acids.,Neocate Nutra has been specifically developed for ... allergy (CMPA) and multiple food protein,intolerance (MFPI). Unlike ...
Cached Medicine News:Health News:IPC The Hospitalist Company Expands Into New Jersey 2Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 2Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 3Health News:nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 4Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 2Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 3Health News:Clinical Innovations Introduces New Circumcision Device 2Health News:First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance 2Health News:First and Only Weaning Product Based on 100% Non-Allergenic Amino-Acids Specifically Designed for Children With Cows' Milk Protein Allergy and Multiple Food Protein Intolerance 3
...
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
The revision knee system for severe joint deterioration with insufficient ligament support....
Medicine Products: